Decision-making in percutaneous coronary intervention: a survey

Catherine R Rahilly-Tierney1, Ira S Nash

  • 1Massachusetts Veterans Epidemiology and Research Information Center (MAVERIC), Boston VA Healthcare System, Boston, Massachusetts, USA. Catherine.Rahilly@va.gov

Insights

Physicians desire more collaboration in percutaneous coronary intervention (PCI) decisions. Most non-cardiologists and cardiologists prefer shared decision-making for PCI, highlighting a gap in current collaborative practices.

Area of Science:

  • Cardiology
  • Medical Decision-Making
  • Health Services Research

Background:

  • Limited research exists on referring physicians' perceptions of collaboration in percutaneous coronary intervention (PCI) decision-making.
  • This study investigates physician perceptions of involvement in PCI decisions referred to a cardiac catheterization lab.

Purpose of the Study:

  • To determine referring physicians' perceptions of their involvement in PCI decision-making.
  • To assess whether physicians consider current collaboration levels optimal.

Main Methods:

  • Anonymous survey distributed to internal medicine faculty at a major academic medical center.
  • Survey assessed perceived inclusion in PCI decisions and preference for collaborative decision-making.

Main Results:

  • 35% response rate (133/378).
  • 89% of non-cardiologists felt PCI decisions were made solely by interventionalists.
  • 92% of cardiologists discussed findings with interventionalists before PCI decisions, and 95% preferred a collaborative approach.

Conclusions:

  • Both non-cardiologists and cardiologists favor involving referring physicians or non-interventional cardiologists in PCI decisions.
  • Cardiologists showed greater alignment between perceived and preferred PCI decision-making processes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...